Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹18,482,242 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹263 Cr
Mar2024₹224 Cr
Mar2023₹220 Cr
Mar2022₹18,482,242 Cr
Mar2017₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹263 Cr
17.45
Mar2024 ₹224 Cr
2.09
Mar2023 ₹220 Cr
-100.00
Mar2022 ₹18,482,242 Cr
10,050,222.98
Mar2017 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,290.6 Cr 2% 25.4% -19.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

2%

25.4%

-19.2%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses